ArticleJournal of diabetes research2021

The Comparison of the Kidney Effects of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide 1 Agonist-Administered Concomitant with Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.

Kazuo Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.